Evaluation of safety and efficacy of prickly heat baby powder in 0-36 months babies

Authors

  • Mohit Poddar Department of Pediatric, NIMS Medical College, Jaipur, Rajasthan, India
  • Sachin Bhargava Dr. Bhargava Clinic, Ghaziabad, Uttar Pradesh, India
  • Mukund Sangamnerkar Department Chinmay Institute of Pediatrics, Pune, Maharashtra, India
  • Rajesh Kumawat Medical Services and Clinical Development, Himalaya Wellness Company, Bengaluru, Karnataka, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20250433

Keywords:

Baby powder, Gentle, Infants, Mild, Prickly heat

Abstract

Background: Given the unique sensitivity of baby skin, this study emphasizes the importance of effective skincare products that cater to the delicate nature of young children's skin. This study was conducted to evaluate the safety, tolerability and efficacy of "Prickly Heat Baby Powder," a polyherbal formulation designed to alleviate symptoms associated with prickly heat in infants and toddlers.

Methods: This was an open-label, single-arm, multicentric study was conducted across 24 medical facilities in India, the trial involved 500 healthy full-term newborns, infants and toddlers aged 0–36 months. Over a 15 (+1) day period, parents/LAR were instructed to apply the powder after bath and nappy changes.

Results: The study assessed product tolerability and efficacy through paediatric evaluations and subjective feedback from parents. Results indicated that 68.6% of subjects experienced significant symptom resolution, with the product rated as mild and gentle for infant skin. No adverse effects were reported and a high acceptance rate was noted among subjects.

Conclusions: The formulation's natural ingredients, including Yashada bhasma, Neem, Karanja and Khus Khus, were highlighted for their antiseptic and anti-inflammatory properties, making it a safe alternative to conventional products. This study supports the potential of herbal formulations in paediatric dermatology and suggest that "Prickly Heat Baby Powder" effectively addresses the discomfort associated with prickly heat, aligning with the growing consumer preference for natural skin care solutions for children.

Metrics

Metrics Loading ...

References

Rahma A, Lane ME. Skin Barrier Function in Infants: Update and Outlook. Pharmaceutics. 2022;14(2):433. DOI: https://doi.org/10.3390/pharmaceutics14020433

Siri DK, Vikas J. Infant’s Skin and Care Needs With Special Consideration To Formulation Additives. Asian J Pharm Clin Res. 2018;11(12):75-81. DOI: https://doi.org/10.22159/ajpcr.2018.v11i12.27384

Atrux-Tallau N, Huynh NT, Gardette L, Pailler-Mattéi C, Zahouani H, Viviant E, et al. Effects of physical and chemical treatments upon biophysical properties and micro-relief of human skin. Arch Dermatol Res. 2008;300(5):243–51. DOI: https://doi.org/10.1007/s00403-008-0849-y

Alanen E, Nuutinen J, Nicklén K, Lahtinen T, Mönkkönen J. Measurement of hydration in the stratum corneum with the Moisture Meter and comparison with the Corneo-meter. Skin Res Technol. 2004;10(1):32–7. DOI: https://doi.org/10.1111/j.1600-0846.2004.00050.x

De Paepe K, Houben E, Adam R, Wiesemann F, Rogiers V. Validation of the Vapo Meter, a closed unventilated chamber system to assess transepidermal water loss vs. the open chamber Tewameter®. Skin Res Technol. 2005;11(1):61–9. DOI: https://doi.org/10.1111/j.1600-0846.2005.00101.x

Wenzel FG, Horn TD. Nonneoplastic disorders of the eccrine glands. J Am Acad Dermatol. 1998;38(1):1–20. DOI: https://doi.org/10.1016/S0190-9622(98)70532-8

Nikolovski J, Stamatas GN, Kollias N, Wiegand BC. Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life. J Investig Dermatol. 2008;128:1728–36. DOI: https://doi.org/10.1038/sj.jid.5701239

Bureau of Indian Standards, 2016, Methods of test for safety evaluation of cosmetics (Third Revision). Available at: https://www.services.bis.gov.in. Accessed on 01st January 2024.

ICH harmonised guideline. Integrated Addendum To ICH E6(R1): Guideline For Good Clinical Practice ICH E6(R2) Current Step 4 version dated 9 November 2016. Available at: https://database. ich.org/sites. Accessed on 21 August 2024.

Cosmetics Europe: Guidelines on the Management of Undesirable Event Report; August,2005, - The Personal Care Association Avenue Herrmann-Debroux 40, 1160 Brussels. Available at: www.cosmeticseurope.eu. Accessed on 01st January 2025.

Marquardt P, Kaft K, Nieber K. Clinical trials with herbal medicinal products in children: a literature analysis. Wien Med Wochenschr. 2015;165(11-12):236-42. DOI: https://doi.org/10.1007/s10354-015-0373-6

Afaq F, Katiyar SK. Polyphenols: skin photoprotection and inhibition of photocarcinogenesis. Mini Rev Med Chem. 2011;11(14):1200-15. DOI: https://doi.org/10.2174/13895575111091200

Datta HS, Mitra SK, Patwardhan B. Wound healing activity of topical application forms based on ayurveda. Evid Based Complement Alternat Med. 2011;1:134378. DOI: https://doi.org/10.1093/ecam/nep015

Subapriya R., Nagini S. Medicinal properties of neem leaves: a review. Curr Med Chem Anticancer Agents. 2005;5(2):149–56. DOI: https://doi.org/10.2174/1568011053174828

Mensah EE, Firempong CK. Chemical characteristics of toilet soap prepared from neem (Azadirachta indica A. Juss) seed oil. Asian J Plant Sci Res. 2011;1(4):1-7.

Mohammad Asif. Antimicrobial Potential of Azadirachta Indica against Pathogenic Bacteria and Fungi. J Pharmacog Phytochem. 2012;1(4)78-83.

Baswa M, Rath CC, Dash SK, Mishra RK. Antibacterial activity of Karanj (Pongamia pinnata) and Neem (Azadirachta indica) seed oil: a preliminary report. Microbios. 2001;105(412):183-9.

Champagnat P, Sidibé L, Forestier C, Carnat A, Chalchat JC, Lamaison JL. Antimicrobial Activity of Essential Oils from Vetiveria nigritana and Vetiveria zizanioides Roots. J Ess Oil Bearing Plants. 2007;10(6):519–24. DOI: https://doi.org/10.1080/0972060X.2007.10643589

Andrea C. Gore. Executive Summary to EDC-2: The endocrine society's second scientific statement on endocrine-disrupting chemicals. Endocrine Rev. 2015;3:593-602. DOI: https://doi.org/10.1210/er.2015-1093

Downloads

Published

2025-02-24

How to Cite

Poddar, M., Bhargava, S., Sangamnerkar, M., & Kumawat, R. (2025). Evaluation of safety and efficacy of prickly heat baby powder in 0-36 months babies. International Journal of Research in Dermatology, 11(2), 139–146. https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20250433

Issue

Section

Original Research Articles